Arkema, chemical specialties, innovative chemistry
Arkema is holding world leading positions on 90% of its business portfolio. Arkema’s strategy is based on innovation, an increased presence in the emerging markets and targeted acquisitions.
Arkema, France’s leading chemicals producer, benefits from strong competitive advantages. This was the outcome of a strategy which for six years has been focused on the expansion in higher growth regions and continuous innovation. This strategy has transformed Arkema into a specialty chemicals player.
By 2016, the Arkema group is aiming to become one of the global leaders in this field and to generate sales of €8 billion, i.e. an annual growth rate of 6%.
What exactly are specialty chemicals?
Specialty chemicals are different from commodity chemicals due to their higher added value, lower tonnages and the fact that there are few players on the world markets.
Specialty chemicals target niche markets and provide specific functionalities and performances. These products are the result of an intensive R&D process.
Significant shift in Arkema's portfolio of activities
Arkema’s financial resources and financial structure will enable it to continue its development through external growth.
As a result of the 2011 acquisition of Total’s speciality resins, Arkema became one of the world’s major producers of coating materials and additives.
In 2012, the Group realized two other major acquisitions: the Seppic’s alkoxylates business and two Chinese companies specialized in biosourced chemicals, Casda Biomaterials and HiPro Polymers.
Since its IPO in 2006, acquisitions and divestments by the Arkema group have each totaled €1.6 billion. As a result, nearly 50% of its portfolio of activities has changed.
Arkema, which recently divested its vinyl business, reorganized its activities into three main business segments: